Literature DB >> 325917

The effect of stored blood on mesenteric oxygen extraction during exdotoxin shock.

D K Garg, L G Kaldis, W C Miller, E D Jacobson, J C Bowen.   

Abstract

Storage of blood in acid-citrate-dextrose (ACD) solution gradually depletes red cell 2,3-diphosphoglycerate (DPG) and increases the affinity of hemoglobin for oxygen. We examined the effect of exchange transfusion of DPG-depleted blood on mesenteric blood flow and oxygen consumption in dogs subjected to endotoxin shock. Two groups of 6 dogs each were anesthetized and subjected to exchange transfusion with either fresh ACD blood or 21-day-old ACD blood prior to administration of Escherichia coli endotoxin (2 mg/kg). Mesenteric blood flow, arteriovenous oxygen content difference and systemic arterial blood pressure were monitored continuously before and for 60 min after endotoxin. Mesenteric blood flow was reduced from 250 +/- 21 ml/min before endotoxin to 114 +/- 15 ml/min at 5 min, 157 +/- 29 ml/min at 30 min, and 112 +/- 17 ml/min at 60 min after endotoxin in the dogs exchanged with fresh blood. Corresponding values for intestinal oxygen consumption were 10.4 +/- 1.0, 7.5 +/- 0.8, 8.4 +/- 1.0, and 6.8 +/- 0.7 ml/min. In dogs transfused with 21-day-old blood, pre-endotoxin blood flow was 208 +/- 2ml/min and declined to 115 +/- 12, 93 +/- 5, and 80 +/- 8 ml/min at 5, 30, and 60 min post-endotoxin. Corresponding values for intestinal oxygen consumption were 8.1 +/- 0.9, 6.6 +/- 0.7, 6.2 +/-0.5, and 5.5 +/- 0.7 ml/min. There was no significant difference (p greater than 0.1) in responses of blood flow or oxygen consumption to endotoxin shock between the two groups of dogs. These findings indicate that exchange transfusion with DPG-depleted blood does not impair oxygen extraction by the ischemic intestine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 325917     DOI: 10.1007/bf01654740

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  Electrodes for blood pO2 and pCO2 determination.

Authors:  J W SEVERINGHAUS; A F BRADLEY
Journal:  J Appl Physiol       Date:  1958-11       Impact factor: 3.531

2.  Advantage or disadvantage of a decrease of blood oxygen affinity for tissue oxygen supply at hypoxia. A theoretical study comparing man and rat.

Authors:  Z Turek; F Kreuzer; L J Hoofd
Journal:  Pflugers Arch       Date:  1973-08-27       Impact factor: 3.657

3.  Evaluation of preservatives and containers for storage of canine blood.

Authors:  D L Eisenbrandt; J E Smith
Journal:  J Am Vet Med Assoc       Date:  1973-10-15       Impact factor: 1.936

4.  Use of biochemical measures to estimate viability of red blood cells in canine blood stored in acid citrate dextrose solution, with and without added ascorbic acid.

Authors:  D L Eisenbrandt; J E Smith
Journal:  J Am Vet Med Assoc       Date:  1973-10-15       Impact factor: 1.936

5.  The respiratory function of blood: transfusion and blood storage.

Authors:  R McConn; J B Derrick
Journal:  Anesthesiology       Date:  1972-02       Impact factor: 7.892

6.  A fable of our time: oxygen transport, or does the emperor have new clothes?

Authors:  M B Laver
Journal:  Anesthesiology       Date:  1972-02       Impact factor: 7.892

7.  An enzymatic assay of 2,3-diphosphoglycerate in blood.

Authors:  S F Nygaard; M Rörth
Journal:  Scand J Clin Lab Invest       Date:  1969-12       Impact factor: 1.713

8.  The basis of defective oxygen delivery from stored blood.

Authors:  H J Sugerman; D T Davidson; S Vibul; M Delivoria-Papadopoulos; L D Miller; F A Oski
Journal:  Surg Gynecol Obstet       Date:  1970-10

9.  Adaptation to exercise: role of hemoglobin affinity for oxygen and 2,3-diphosphoglycerate.

Authors:  S D Shappell; J A Murray; A J Bellingham; R D Woodson; J C Detter; C Lenfant
Journal:  J Appl Physiol       Date:  1971-06       Impact factor: 3.531

10.  Benefits from improved oxygen delivery of blood in shock therapy.

Authors:  C L Rice; C M Herman; L A Kiesow; L D Homer; D A John
Journal:  J Surg Res       Date:  1975-09       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.